Discovery Platform
A Powerful Tech Stack for Validating Difficult Targets
Epitope-Steering and Antibody Optimization
Collaborating to develop first-in-class and best-in-class molecules for obesity, diabetes, and heart disease
RAPIDLY ADVANCING HARD-TO-ENGINEER ANTIBODIES
Advancing our preclinical pipeline and innovating with our partners to overcome oncology’s discovery and development challenges
License our discovery platform or collaborate with us to advance our high-value pipeline assets
From precision antibody identification and optimization to tailored bispecifics and a cutting-edge masking technology
An antibody masking technology for delivering on-epitope, on-tissue clinical candidates with enhanced safety and developability
a CD3-BASED T-CELL ENGAGER Platform
Learn how we are deploying our AI Drug Discovery Platform to develop a robust immuno-oncology pipeline
Meet the team driving iBio’s powerful tech stack for drug discovery
For Investor inquiries, please visit our Investor Site